NZ595969A - Use of galacto-oligosaccharide in the prevention of an inflammatory disorder - Google Patents
Use of galacto-oligosaccharide in the prevention of an inflammatory disorderInfo
- Publication number
- NZ595969A NZ595969A NZ595969A NZ59596910A NZ595969A NZ 595969 A NZ595969 A NZ 595969A NZ 595969 A NZ595969 A NZ 595969A NZ 59596910 A NZ59596910 A NZ 59596910A NZ 595969 A NZ595969 A NZ 595969A
- Authority
- NZ
- New Zealand
- Prior art keywords
- beta
- gal
- prevention
- inflammatory disorder
- galacto
- Prior art date
Links
- 235000021255 galacto-oligosaccharides Nutrition 0.000 title abstract 2
- 150000003271 galactooligosaccharides Chemical class 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- DLRVVLDZNNYCBX-JZSVMVJISA-N beta-D-Galp-(1->6)-D-Galp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-JZSVMVJISA-N 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000004044 tetrasaccharides Chemical class 0.000 abstract 1
- 150000004043 trisaccharides Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0906983.2A GB0906983D0 (en) | 2009-04-23 | 2009-04-23 | Novel use |
| GBGB0920784.6A GB0920784D0 (en) | 2009-04-23 | 2009-11-27 | Novel use |
| PCT/GB2010/050659 WO2010122344A1 (en) | 2009-04-23 | 2010-04-23 | Novel use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595969A true NZ595969A (en) | 2013-03-28 |
Family
ID=40774842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595969A NZ595969A (en) | 2009-04-23 | 2010-04-23 | Use of galacto-oligosaccharide in the prevention of an inflammatory disorder |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20120058972A1 (https=) |
| EP (1) | EP2421541B1 (https=) |
| JP (1) | JP2012524770A (https=) |
| KR (1) | KR20110138416A (https=) |
| CN (1) | CN102427818A (https=) |
| AU (1) | AU2010240642B2 (https=) |
| BR (1) | BRPI1015091A2 (https=) |
| CA (1) | CA2759442C (https=) |
| CY (1) | CY1120597T1 (https=) |
| DK (1) | DK2421541T3 (https=) |
| ES (1) | ES2688786T3 (https=) |
| GB (3) | GB0906983D0 (https=) |
| HU (1) | HUE040451T2 (https=) |
| IL (1) | IL215855A0 (https=) |
| MX (1) | MX341308B (https=) |
| MY (1) | MY151104A (https=) |
| NZ (1) | NZ595969A (https=) |
| PL (1) | PL2421541T3 (https=) |
| PT (1) | PT2421541T (https=) |
| RU (1) | RU2530567C2 (https=) |
| SG (1) | SG175313A1 (https=) |
| TR (1) | TR201810868T4 (https=) |
| UA (1) | UA106491C2 (https=) |
| WO (1) | WO2010122344A1 (https=) |
| ZA (1) | ZA201107821B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2492559B (en) * | 2011-07-05 | 2018-07-25 | Clasado Inc | Composition and method for preventing or reducing the risk of developing a syndrome |
| DK2734210T3 (en) | 2011-07-22 | 2018-01-22 | Abbott Lab | GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL |
| CN103716787B (zh) | 2012-09-29 | 2020-06-23 | 北京三星通信技术研究有限公司 | 一种支持对家用基站进行验证的方法 |
| CN107771083A (zh) * | 2015-04-23 | 2018-03-06 | 卡莱多生物科技有限公司 | 聚糖治疗剂和治疗方法 |
| CN107158011A (zh) * | 2017-05-25 | 2017-09-15 | 浙江大学 | 低聚半乳糖在制备治疗肠道疾病的药物中的用途 |
| US12508273B2 (en) | 2019-05-15 | 2025-12-30 | N.V. Nutricia | Beta-1,3′-galactosyllactose for the treatment of gut barrier function diseases |
| US20240277739A1 (en) * | 2021-07-01 | 2024-08-22 | N.V. Nutricia | Nutritonal compositions for gut barrier function |
| KR102453998B1 (ko) * | 2022-01-07 | 2022-10-14 | (주)네오크레마 | 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물 |
| GB2619977A (en) * | 2022-06-24 | 2023-12-27 | Clasado Res Services Limited | Compositions and uses thereof |
| GB2623336A (en) * | 2022-10-12 | 2024-04-17 | Clasado Res Services Limited | Compositions and uses thereof |
| GB2623335A (en) * | 2022-10-12 | 2024-04-17 | Clasado Res Services Limited | Compositions and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0229015D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| GB0315266D0 (en) * | 2003-06-30 | 2003-08-06 | Clasado Inc | Novel galactooligosaccharide composition and the preparation thereof |
| ATE360682T1 (de) * | 2003-06-30 | 2007-05-15 | Clasado Inc | Neue galactooligosaccharidzusammensetzung und herstellung davon |
| EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| EP1887017A1 (en) * | 2006-08-09 | 2008-02-13 | Friesland Brands B.V. | Prebiotic carbohydrate |
| GB0809921D0 (en) | 2008-05-30 | 2008-07-09 | Clasado Inc | Product and process therefor |
-
2009
- 2009-04-23 GB GBGB0906983.2A patent/GB0906983D0/en not_active Ceased
- 2009-11-27 GB GBGB0920784.6A patent/GB0920784D0/en not_active Ceased
-
2010
- 2010-04-23 CN CN2010800180409A patent/CN102427818A/zh active Pending
- 2010-04-23 AU AU2010240642A patent/AU2010240642B2/en active Active
- 2010-04-23 TR TR2018/10868T patent/TR201810868T4/tr unknown
- 2010-04-23 MY MYPI2011004912 patent/MY151104A/en unknown
- 2010-04-23 CA CA2759442A patent/CA2759442C/en active Active
- 2010-04-23 GB GB1120030.0A patent/GB2482817B/en active Active
- 2010-04-23 RU RU2011147390/15A patent/RU2530567C2/ru not_active IP Right Cessation
- 2010-04-23 BR BRPI1015091A patent/BRPI1015091A2/pt not_active Application Discontinuation
- 2010-04-23 US US13/265,532 patent/US20120058972A1/en not_active Abandoned
- 2010-04-23 JP JP2012506581A patent/JP2012524770A/ja active Pending
- 2010-04-23 NZ NZ595969A patent/NZ595969A/xx not_active IP Right Cessation
- 2010-04-23 KR KR1020117027762A patent/KR20110138416A/ko not_active Ceased
- 2010-04-23 PT PT10714956T patent/PT2421541T/pt unknown
- 2010-04-23 ES ES10714956.9T patent/ES2688786T3/es active Active
- 2010-04-23 WO PCT/GB2010/050659 patent/WO2010122344A1/en not_active Ceased
- 2010-04-23 SG SG2011077443A patent/SG175313A1/en unknown
- 2010-04-23 MX MX2011011159A patent/MX341308B/es active IP Right Grant
- 2010-04-23 PL PL10714956T patent/PL2421541T3/pl unknown
- 2010-04-23 HU HUE10714956A patent/HUE040451T2/hu unknown
- 2010-04-23 UA UAA201113760A patent/UA106491C2/uk unknown
- 2010-04-23 DK DK10714956.9T patent/DK2421541T3/en active
- 2010-04-23 EP EP10714956.9A patent/EP2421541B1/en not_active Revoked
-
2011
- 2011-10-23 IL IL215855A patent/IL215855A0/en unknown
- 2011-10-25 ZA ZA2011/07821A patent/ZA201107821B/en unknown
-
2018
- 2018-08-13 CY CY181100857T patent/CY1120597T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2421541T (pt) | 2018-10-15 |
| RU2011147390A (ru) | 2013-05-27 |
| SG175313A1 (en) | 2011-11-28 |
| MX2011011159A (es) | 2011-11-07 |
| CN102427818A (zh) | 2012-04-25 |
| IL215855A0 (en) | 2012-01-31 |
| WO2010122344A1 (en) | 2010-10-28 |
| GB2482817B (en) | 2014-02-26 |
| MX341308B (es) | 2016-08-12 |
| CY1120597T1 (el) | 2019-12-11 |
| CA2759442A1 (en) | 2010-10-28 |
| DK2421541T3 (en) | 2018-09-24 |
| EP2421541B1 (en) | 2018-07-11 |
| JP2012524770A (ja) | 2012-10-18 |
| BRPI1015091A2 (pt) | 2016-04-26 |
| TR201810868T4 (tr) | 2018-08-27 |
| AU2010240642A1 (en) | 2011-11-10 |
| KR20110138416A (ko) | 2011-12-27 |
| ZA201107821B (en) | 2012-07-25 |
| GB201120030D0 (en) | 2012-01-04 |
| US20120058972A1 (en) | 2012-03-08 |
| AU2010240642B2 (en) | 2013-03-14 |
| HUE040451T2 (hu) | 2019-03-28 |
| MY151104A (en) | 2014-04-15 |
| EP2421541A1 (en) | 2012-02-29 |
| CA2759442C (en) | 2016-01-19 |
| GB2482817A (en) | 2012-02-15 |
| GB0906983D0 (en) | 2009-06-03 |
| RU2530567C2 (ru) | 2014-10-10 |
| UA106491C2 (uk) | 2014-09-10 |
| GB0920784D0 (en) | 2010-01-13 |
| ES2688786T3 (es) | 2018-11-06 |
| PL2421541T3 (pl) | 2018-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595969A (en) | Use of galacto-oligosaccharide in the prevention of an inflammatory disorder | |
| PH12015501309A1 (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
| BR112014015940A2 (pt) | composição de novo fármaco de carboidrato para tratamento de doenças humanas | |
| NZ588185A (en) | Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes | |
| MY184985A (en) | Oligosaccharide mixture and food product comprising this mixture, especially infant formula | |
| MX346335B (es) | Composiciones antisentido, y metodos para obtener y usar las mismas. | |
| MY161127A (en) | Enhanced soluble c5 saccharide yields | |
| PH12013500971A1 (en) | Oligosaccharide mixture and food product comprising this mixture, especially infant formula | |
| MY168759A (en) | Pharmaceutical compositions comprising modified fucans and methods relating thereto | |
| PH12013500892B1 (en) | Composition for use in the prevention and\or treatment of skin conditions and skin diseases | |
| MX347753B (es) | Formulaciones resistentes al abuso. | |
| HUE068442T2 (hu) | Az immunrendszer stimulálására szolgáló, emészthetetlen oligoszacharidok keveréke | |
| SG170024A1 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
| MX351104B (es) | Nuevos glucosaminoglucanos con baja actividad anticoagulante. | |
| WO2011140208A3 (en) | Methods and compositions for diagnosing and treating autoimmune disorders | |
| IN2015DN02907A (https=) | ||
| MX2011010036A (es) | Sales de 6'-sialil-lactosa y procesos para su sintesis y para la sintesis de otros alfa-sialil-oligosacaridos. | |
| JP2012524770A5 (https=) | ||
| NZ611316A (en) | Histone inhibition | |
| IN2014CN02908A (https=) | ||
| AU2009347008A8 (en) | Method of preventing diarrhoea | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| WO2011039629A3 (es) | Fracción bioactiva de petiveria alliacea, composición farmacéutica que la contiene y combinación con agentes inmunoestimulantes para el tratamiento del cáncer | |
| TR201908669T4 (tr) | N-desülfatlanmış glikozaminoglikanların türevleri ve ilaç olarak kullanımı. | |
| WO2013022836A3 (en) | Pmst1 mutants for chemoenzymatic synthesis of sialyl lewis x compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 23 APR 2017 BY JAMES + WELLS Effective date: 20140319 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 APR 2018 BY JAMES + WELLS Effective date: 20170410 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 APR 2019 BY JAMES + WELLS Effective date: 20180222 |
|
| LAPS | Patent lapsed |